Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?-Reference-Cited by-同舟云学术

Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?

Published:2013-08-08 Issue:1 Volume:2 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Johansen Kristian B,Balchen Torben

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/2162-3619-2-21.pdf

Reference40 articles.

1. Bisio A, Vecchietti D, Citterio L, Guerrini M, Raman R, Bertini S, Eisele G, Naggi A, Sasisekharan R, Torri G: Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Thromb Haemost 2009, 102: 865–873.

2. Hoy SM, Scott LJ, Plosker GL: Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis. Drugs 2010, 70: 1319–1347. 10.2165/11203710-000000000-00000

3. Monreal M, Falgá C, Valle R, Barba R, Bosco J, Beato JL, Maestre A: Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med 2006, 119: 1073–1079. 10.1016/j.amjmed.2006.04.028

4. Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G, On behalf of the Renal Insufficiency and Cancer Medications (IRMA) Study Group: Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 2007, 110: 1376–1384. 10.1002/cncr.22904

5. LEO Laboratories Limited: Innohep® 20,000 IU/ml and Innohep syringe 20,000 IU/ml Summary of Product Characteristics. 2011. http://www.medicines.org.uk/emc/medicine/5176/SPC

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study;Thrombosis Research;2024-04

2. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05

3. Perioperatives Management der oralen Antikoagulation;Allgemein- und Viszeralchirurgie up2date;2024-03

4. Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis;Thrombosis Journal;2024-02-05

5. Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions;Clinical Pharmacokinetics;2023-10-12